Boston Scientific (BSX) Interest Coverage Ratio Growth (3y) (2012 - 2026)
Boston Scientific (BSX) Interest Coverage Ratio Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | -20.77% |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 8.34% |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 18.67% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 15.93% |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -50.44% |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 43.57% |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -33.11% |
| Mar 31, 2026 | -36.73% |
| Dec 31, 2025 | 13.43% |
| Sep 30, 2025 | 28.46% |
| Jun 30, 2025 | -34.80% |
| Mar 31, 2025 | 88.75% |
| Dec 31, 2024 | 135.43% |
| Sep 30, 2024 | 27.28% |
| Jun 30, 2024 | 30.39% |
| Mar 31, 2024 | 29.43% |
| Dec 31, 2023 | 166.86% |
| Sep 30, 2023 | 85.71% |
| Jun 30, 2023 | 125.14% |
| Mar 31, 2023 | 72.34% |
| Dec 31, 2022 | 74.94% |
| Sep 30, 2022 | 12.12% |
| Jun 30, 2022 | 15.28% |
| Mar 31, 2022 | -30.44% |
| Dec 31, 2021 | -25.40% |
| Sep 30, 2021 | -12.38% |